Toll-like receptor 3 expression in Glia and neurons alters in response to white matter injury in preterm infants

Developmental Neuroscience

Volumn 35, Issue 2-3, 2013, Pages 130-139

  Vontell, R ^a,c   Supramaniam, V ^a,b   Thornton, C ^a,c   Wyatt Ashmead, J ^a,d   Mallard, C ^e   Gressens, P ^a,f   Rutherford, M ^a,b   Hagberg, H ^a,c,e  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d ST MARY S HOSPITAL   (United Kingdom)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f INSERM   (France)

Author keywords

Astrocytes; Inflammation; Neuronal proliferation; Toll like receptor 3; White matter injury

Indexed keywords

TOLL LIKE RECEPTOR 3; GLIAL FIBRILLARY ACIDIC PROTEIN; NEURON SPECIFIC NUCLEAR PROTEIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2;

ASTROCYTE; BRAIN TISSUE; CLINICAL ARTICLE; CONFERENCE PAPER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; GLIA; GLIA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; MACROGLIA; MALE; MICROGLIA; NERVE CELL; OLIGODENDROGLIA; PARIETAL LOBE; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SECTION; WHITE MATTER INJURY; BRAIN DEVELOPMENT; CELL PROLIFERATION; FETUS DEVELOPMENT; FRONTAL CORTEX; GESTATIONAL AGE; GRAY MATTER; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL CORTEX; WHITE MATTER;

BRAIN; BRAIN INJURIES; HUMANS; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; NERVE FIBERS, MYELINATED; NEUROGLIA; NEURONS; TOLL-LIKE RECEPTOR 3;

EID: 84880199810     PISSN: 03785866     EISSN: 14219859     Source Type: Journal    
DOI: 10.1159/000346158     Document Type: Conference Paper

References (33)

1. Volpe JJ: Brain injury in premature infants: A complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009; 8: 110-124.
2. Bystron I, Blakemore C, Rakic P: Development of the human cerebral cortex: Boulder Committee revisited. Nat Rev Neurosci 2008; 9: 110-122.
3. Back SA, Riddle A, McClure MM: Maturation-dependent vulnerability of perinatal white matter in premature birth. Stroke 2007; 38: 724-730.
4. Judas M, Rados M, Jovanov-Milosevic N, Hrabac P, Stern-Padovan R, Kostovic I: Structural, immunocytochemical, and MR imaging properties of periventricular crossroads of growing cortical pathways in preterm infants. AJNR Am J Neuroradiol 2005; 26: 2671-2784.
5. Billiards SS, Haynes RL, Folkerth RD, Borenstein NS, Trachtenberg FL, Rowitch DH, Ligon KL, Volpe JJ, Kinney HC: Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia. Brain Pathol 2008; 18: 153-163.
6. Vasung L, Huang H, Jovanov-Milosevic N, Pletikos M, Mori S, Kostovic I: Development of axonal pathways in the human fetal frontolimbic brain: Gistochemical characterization and diffusion tensor imaging. J Anat 2010; 217: 400-417.
7. Counsell SJ, Dyet LE, Larkman DJ, Nunes RG, Boardman JP, Allsop JM, Fitzpatrick J, Srinivasan L, Cowan FM, Hajnal JV, Rutherford MA, Edwards AD: Thalamo-cortical connectivity in children born preterm mapped using probabilistic magnetic resonance tractography. Neuroimage 2007; 34: 896-904.
8. Haynes RL, Xu G, Folkerth RD, Trachtenberg FL, Volpe JJ, Kinney HC: Potential neuronal repair in cerebral white matter injury in the human neonate. Pediatr Res 2011; 69: 62-67.
9. Leviton A, Gressens P: Neuronal damage accompanies perinatal white-matter damage. Trends Neurosci 2007; 30: 473-478.
10. Rodts-Palenik S, Wyatt-Ashmead J, Pang Y, Thigpen B, Cai Z, Rhodes P, Martin JN, Granger J, Bennett WA: Maternal infectioninduced white matter injury is reduced by treatment with interleukin-10. Am J Obstet Gynecol 2004; 191: 1387-1392.
11. Kinney HC, Back SA: Guman oligodendroglial development: Relationship to periventricular leukomalacia. Semin Pediatr Neurol 1998; 5: 180-189.
12. Volpe JJ: Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 2001; 50: 553-562.
13. Volpe JJ: Neurology of the Newborn, ed 5. Philadelphia, Saunders Elsevier, 2008.
14. Back S, Volpe J: Cellular and Molecular Pathogenesis of Periventricular White Matter Injury. Ment Retard Dev Disabil Res Rev 1997; 3: 96-107.
15. Roelants-van Rijn AM, Groenendaal F, Beek FJ, Eken P, van Haastert IC, de Vries LS: Parenchymal brain injury in the preterm infant: Comparison of cranial ultrasound, MRI and neurodevelopmental outcome. Neuropediatrics 2001; 32: 80-89.
16. Ligam P, Haynes RL, Folkerth RD, Liu L, Yang M, Volpe JJ, Kinney HC: Thalamic damage in periventricular leukomalacia: Novel pathologic observations relevant to cognitive deficits in survivors of permaturity. Pediatr Res 2009; 65: 524-529.
17. Ajayi-Obe M, Saeed N, Cowan FM, Rutherford MA, Edwards AD: Reduced development of cerebral cortex in extremely preterm infants. Lancet 2000; 356: 1162-1163.
18. Inder T, Neil J, Yoder B, Rees S: Patterns of cerebral injury in a primate model of preterm birth and neonatal intensive care. J Child Neurol 2005; 20: 965-967.
19. Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, Volpe JJ, Vartanian T: Activation of innate immunity in the CNS triggers neurodegeneration through a Tolllike receptor 4-dependent pathway. Proc Natl Acad Sci USA 2003; 100: 8514-8519.
20. Hagberg H, Mallard C: Effect of inflammation on central nervous system development and vulnerability. Curr Opin Neurol 2005; 18: 117-123.
21. Thornton C, Rousset CI, Kichev A, Miyakuni Y, Vontell R, Baburamani AA, Fleiss B, Gressens P, Hagberg H: Molecular mechanisms of neonatal brain injury. Neurol Res Int 2012; 2012: 506320.
22. Colton C: Geterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 2009; 4: 399-418.
23. Botos I, Segal DM, Davies DR: The structural biology of toll-like receptors. Structure 2011; 19: 447-459.
24. Wang CY, Lin S, Yang QW: Toll-like receptors in cerebral ischemic inflammatory injury. J Neuroinflammation 2011; 8: 1-11.
25. Rolls A, Shechter R, London A, Ziv Y, Ronen A, Levy R, Schwartz M: Toll-like receptors modulate adult hippocampal neurogenesis. Nat Cell Biol 2007; 9: 1081-1088.
26. Cameron JS, Alexopoulou L, Sloane JA, DiBernardo BA, Ma Y, Kosaras B, Flavell R, Strittmatter SM, Volpe J, Sidman R, Vartanian T: Toll-Like receptor 3 is a potent negative regulator of axonal growth in mammals. J Neurosci 2007; 27: 13033-13041.
27. Lathia JD, Okun E, Tang SC, Griffioen K, Cheng A, Mughal MR, Laryea G, Selvaraj PK, Ffrench-Constant C, Magnus T, Arumugam TV, Mattson MP: TLR3 is a negative regulator of embryonic neural progenitor cell proliferation. J Neurosci 2008; 28: 13978-13984.
28. Bsibsi M, Bajramovic JJ, Vogt MH, van Duijvenvoorden E, Baghat A, Persoon-Deen C, Tielen F, Verbeek R, Huitinga I, Ryffel B, Kros A, Gerritsen WH, Amor S, van Noort JM: The microtubule regulator stathmin is an endogenous protein agonist for TLR3. J Immunol 2010; 184: 6929-6937.
29. Sun R, Zhang Y, Lv Q, Liu B, Jin M, Zhang W, He Q, Deng M, Liu X, Li G, Li Y, Zhuo G, Xie P, Xie X, Duan Z, Hu J: Toll-like receptor 3 (TLR3) induces apoptosis via death receptors and mitochondria by up-regulating the transactivating p63 isoform α (TAP63α). J. Biol-Chem 2011; 286: 15918-15928.
30. Glaser J, Greene G, Hendricks S: Stereology for Biological Research. Williston, MBF Press, 2007, pp 44-49.
31. Supramaniam V, Vontell R, Srinivasan L, Wyatt-Ashmead J, Hagberg H, Rutherford M: Microglia activation in the extremely preterm human brain. Pediatr Res, accepted.
32. Deleidi M, Hallett PJ, Koprich JB, Chung C, Isacson O: The toll-like receptor-3 agonist polyinosinic:polycytidylic acid triggers nigrostriatal dopamingergic degeneration. J Neurosci 2010; 30: 16091-16101.
33. Dean JM, van de Looij Y, Sizonenko SV, Lodygensky GA, Lazeyras F, Bolouri H, Kjellmer I, Huppi PS, Hagberg H, Mallard C: Delayed cortical impairment following lipopolysaccharide exposure in preterm fetal sheep. Ann Neurol 2011; 70: 846-856.